QuidelOrtho Net Profit Margin 2010-2024 | QDEL
QuidelOrtho net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| QuidelOrtho Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-12-31 | $2.78B | $-2.05B | -73.73% |
| 2024-09-30 | $2.82B | $-1.87B | -66.25% |
| 2024-06-30 | $2.84B | $-1.86B | -65.61% |
| 2024-03-31 | $2.86B | $-1.77B | -61.65% |
| 2023-12-31 | $3.00B | $-0.01B | -0.33% |
| 2023-09-30 | $3.12B | $0.01B | 0.42% |
| 2023-06-30 | $3.16B | $0.05B | 1.42% |
| 2023-03-31 | $3.11B | $0.12B | 3.76% |
| 2022-12-31 | $3.27B | $0.55B | 16.78% |
| 2022-09-30 | $3.04B | $0.81B | 26.65% |
| 2022-06-30 | $2.76B | $1.01B | 36.42% |
| 2022-03-31 | $2.33B | $1.01B | 43.25% |
| 2021-12-31 | $1.70B | $0.70B | 41.44% |
| 2021-09-30 | $1.87B | $0.88B | 47.19% |
| 2021-06-30 | $1.84B | $0.90B | 48.94% |
| 2021-03-31 | $1.86B | $0.95B | 50.91% |
| 2020-12-31 | $1.66B | $0.81B | 48.74% |
| 2020-09-30 | $1.01B | $0.37B | 36.92% |
| 2020-06-30 | $0.66B | $0.16B | 23.66% |
| 2020-03-31 | $0.56B | $0.09B | 15.69% |
| 2019-12-31 | $0.53B | $0.07B | 13.67% |
| 2019-09-30 | $0.52B | $0.07B | 14.37% |
| 2019-06-30 | $0.51B | $0.07B | 13.64% |
| 2019-03-31 | $0.50B | $0.07B | 12.97% |
| 2018-12-31 | $0.52B | $0.07B | 14.18% |
| 2018-09-30 | $0.50B | $0.04B | 7.34% |
| 2018-06-30 | $0.44B | $0.02B | 4.57% |
| 2018-03-31 | $0.37B | $0.01B | 2.95% |
| 2017-12-31 | $0.28B | $-0.01B | -3.24% |
| 2017-09-30 | $0.22B | $-0.01B | -2.78% |
| 2017-06-30 | $0.21B | $0.00B | -0.47% |
| 2017-03-31 | $0.22B | $0.00B | 1.40% |
| 2016-12-31 | $0.19B | $-0.01B | -7.33% |
| 2016-09-30 | $0.19B | $-0.01B | -6.32% |
| 2016-06-30 | $0.19B | $-0.01B | -6.38% |
| 2016-03-31 | $0.18B | $-0.01B | -7.07% |
| 2015-12-31 | $0.20B | $-0.01B | -3.06% |
| 2015-09-30 | $0.21B | $0.00B | 0.48% |
| 2015-06-30 | $0.20B | $0.00B | -1.97% |
| 2015-03-31 | $0.20B | $0.00B | -1.01% |
| 2014-12-31 | $0.18B | $-0.01B | -4.35% |
| 2014-09-30 | $0.17B | $-0.01B | -8.19% |
| 2014-06-30 | $0.16B | $-0.01B | -7.32% |
| 2014-03-31 | $0.16B | $-0.01B | -4.29% |
| 2013-12-31 | $0.18B | $0.01B | 3.93% |
| 2013-09-30 | $0.18B | $0.02B | 8.33% |
| 2013-06-30 | $0.18B | $0.02B | 10.06% |
| 2013-03-31 | $0.18B | $0.02B | 9.44% |
| 2012-12-31 | $0.16B | $0.01B | 3.21% |
| 2012-09-30 | $0.14B | $0.00B | -2.14% |
| 2012-06-30 | $0.14B | $0.00B | -2.14% |
| 2012-03-31 | $0.14B | $0.00B | -2.92% |
| 2011-12-31 | $0.16B | $0.01B | 4.40% |
| 2011-09-30 | $0.15B | $0.01B | 3.92% |
| 2011-06-30 | $0.15B | $0.00B | 0.68% |
| 2011-03-31 | $0.15B | $0.00B | 2.07% |
| 2010-12-31 | $0.11B | $-0.01B | -9.73% |
| 2010-09-30 | $0.15B | $0.01B | 6.08% |
| 2010-06-30 | $0.18B | $0.03B | 17.05% |
| 2010-03-31 | $0.18B | $0.03B | 18.75% |
| 2009-12-31 | $0.17B | $0.03B | 20.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.263B | $2.783B |
| QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.530B | 28.20 |
| Boston Scientific (BSX) | United States | $156.880B | 39.27 |
| Stryker (SYK) | United States | $150.466B | 31.46 |
| EssilorLuxottica (ESLOY) | France | $133.537B | 0.00 |
| Medtronic (MDT) | Ireland | $110.863B | 16.19 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.634B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.687B | 27.69 |
| ResMed (RMD) | United States | $36.905B | 27.72 |
| GE HealthCare Technologies (GEHC) | United States | $33.485B | 15.90 |
| Agilent Technologies (A) | United States | $32.436B | 21.43 |
| Terumo (TRUMY) | Japan | $27.642B | 35.90 |
| Insulet (PODD) | United States | $22.854B | 89.71 |
| Koninklijke Philips (PHG) | Netherlands | $22.587B | 16.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.181B | 12.32 |
| Baxter (BAX) | United States | $16.247B | 12.13 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.648B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.231B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.767B | 23.55 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 14.18 |
| Prestige Consumer Healthcare (PBH) | United States | $4.402B | 19.67 |
| Perrigo (PRGO) | Ireland | $3.719B | 9.43 |
| Haemonetics (HAE) | United States | $3.532B | 15.39 |
| ICU Medical (ICUI) | United States | $3.480B | 25.66 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.097B | 25.73 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| LeMaitre Vascular (LMAT) | United States | $1.915B | 42.81 |
| AtriCure (ATRC) | United States | $1.619B | 0.00 |
| Neogen (NEOG) | United States | $1.435B | 18.36 |
| Kestra Medical Technologies (KMTS) | United States | $1.264B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Green Thumb Industries (GTBIF) | United States | $1.182B | 26.59 |
| BioLife Solutions (BLFS) | United States | $1.121B | 0.00 |
| InMode (INMD) | Israel | $1.020B | 9.34 |
| Phibro Animal Health (PAHC) | United States | $0.973B | 12.44 |
| CeriBell (CBLL) | United States | $0.649B | 0.00 |
| Evolus (EOLS) | United States | $0.625B | 0.00 |
| Owens & Minor (OMI) | United States | $0.570B | 4.73 |
| Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.535B | 0.00 |
| Valneva SE (VALN) | France | $0.524B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.498B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.431B | 0.00 |
| Surmodics (SRDX) | United States | $0.409B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.335B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.94 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.321B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.305B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.288B | 51.30 |
| Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.276B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 22.53 |
| Cerus (CERS) | United States | $0.254B | 0.00 |
| ZimVie (ZIMV) | United States | $0.251B | 11.41 |
| Verano Holdings (VRNOF) | United States | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.224B | 6.31 |
| High Tide (HITI) | Canada | $0.191B | 0.00 |
| Omeros (OMER) | United States | $0.187B | 0.00 |
| Brainsway (BWAY) | Israel | $0.187B | 49.55 |
| Quanterix (QTRX) | United States | $0.186B | 0.00 |
| Organigram Global (OGI) | Canada | $0.182B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.182B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 14.58 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| Exagen (XGN) | United States | $0.128B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.77 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.080B | 10.32 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.061B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.35 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 30.86 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |